Procter & Gamble's first quarter of fiscal 2027 delivered organic sales growth of 4 percent, up from the prior year's 3.3 percent, driven b
Read moreDetailsSubscribe to our mailing list to receives daily updates direct to your inbox!
Abbott Laboratories spent most of the pandemic era as a Wall Street darling, its COVID test sales turning a steady...
GE Aerospace lifted full-year profit and cash flow targets after third-quarter orders jumped 58 percent, driven by a backlog of...
The short version Krystal Biotech built a profitable, cash-rich business on a single gene therapy approved just three years ago....
Three things that should not all be true at...
For most of the past two years, the Federal...
The quick read The third estimate for Q2 2026,...
Abbott Laboratories spent most of the pandemic era as a...
Three things that should not all be true at once...
BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.
